Loading provider…
Loading provider…
Nephrology Physician in Nashville, TN
NPI: 1295882165Primary Practice Location
VANDERBILT UNIVERSITY MEDICAL CENTER
2200 Childrens Way, Nashville, TN
Primary Employer
Vanderbilt Medical Group
vanderbilthealth.com
HQ Phone
Get MD James's Phone NumberMobile
Get MD James's MobileLooking to connect with more Physicians?
Dmand AI gives you access to real-time firmographics, buying signals, org charts, and decision-makers - helping your GTM teams prioritize accounts, personalize outreach with AI-driven automation, and close deals faster.
Get Started for Freearrow_outwardTN State Medical License
| # | Procedure Code (CPT®/HCPCS II) | Procedure Patients | Procedure Volume |
|---|---|---|---|
| 1 | 99214Established patient office or other outpatient visit, 30-39 minutes | 104 | 155 |
| 2 | 99204New patient office or other outpatient visit, 45-59 minutes | 28 | 28 |
| 3 | 99222Initial hospital care with straightforward or low-level medical decision making, if using time, at least 55 minutes | 15 | 15 |
Medicare reimbursement policy for ambulatory blood pressure monitoring: A qualitative analysis of public comments to the Centers for Medicare and Medicaid Services.
Authors: James Byrd
Publication Date: 2019-07-03
Authors: Katherine Cahill, Jessica Devin, Joshua Beckman, John Koethe, Jonathan Brown, Kevin Niswender
Journal: Diabetes Obes Metab
Publication Date: 2022-11-10
The renin-angiotensin-aldosterone system and glucose homeostasis.
Authors: Luther, James Matthew, Brown, Nancy J
Journal: Trends Pharmacol Sci
Publication Date: 2011-08-29
Lead Sponsor: Vanderbilt University Medical Center
Collaborators: National Institutes of Health (NIH), National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)
Intervention / Treatment: DRUG: Placebo oral capsule, DRUG: GSK2256294
Lead Sponsor: University of British Columbia
Collaborators: Canadian Institutes of Health Research (CIHR)
Intervention / Treatment: DRUG: Telmisartan, DRUG: Irbesartan, DRUG: Losartan, DRUG: Valsartan, DRUG: Eprosartan, DRUG: Olmesartan, DRUG: Azilsartan, DRUG: Candesartan
Lead Sponsor: Vanderbilt University
Collaborators: National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK), Brigham and Women's Hospital
Intervention / Treatment: OTHER: Adrenalectomy, DRUG: mineralocorticoid receptor antagonist